Onyx Biotec IPO
ListedOnyx Biotec IPO Details
-
Bidding Date
13-Nov-2024 to
18-Nov-2024 -
Issue Size
₹29.34 Cr
-
Price Band
₹58 to ₹61
-
Allotment date
19-Nov-2024
-
Listing date
22-Nov-2024
-
Lot size
2000
-
No. of shares
48,10,000
-
Fresh issue/OFS
₹29.34 Cr /--
About Onyx Biotec Company
Onyx Biotec is a pharmaceutical contract manufacturer specializing in sterile pharmaceutical products. The company started its operations in the pharmaceutical industry in 2010, initially with sterile water for injections. Over the years, Onyx expanded its product portfolio to include Dry Powder Injections and Dry Syrup for both domestic and international markets. Their core business is focused on providing end-to-end product development and manufacturing solutions, which includes the preparation and filing of regulatory dossiers for the Indian and global markets. The company supplies to major pharmaceutical companies across India and globally, including Hetero Healthcare, Mankind Pharma, Sun Pharmaceutical, Aristo Pharmaceuticals, and others. the company manufactures these products in two facilities in Himachal Pradesh, with modern equipment and sustainable practices in place.
Subscription Status
-
Category
Status
-
QIBs
--
-
NIIs
--
-
Retail
--
-
Others
--
-
Total
183.9x
FAQs for Onyx Biotec IPO.
What is the issue size of Onyx Biotec IPO?
The issue size of Onyx Biotec is ₹29.34 Cr.
What is the industry of Onyx Biotec?
Onyx Biotec falls into Healthcare Devices & Equipment industry.
Where Onyx Biotec IPO will be listed?
The Onyx Biotec IPO will be listed on BSE.
What are the open and close dates for the Onyx Biotec IPO?
The open and close dates for the Onyx Biotec are 13-Nov-2024 & 18-Nov-2024.
What are the price band for Onyx Biotec IPO?
The price band for the Onyx Biotec ipo is ₹58 to ₹61
What is the listing date of Onyx Biotec IPO?
The listing date of Onyx Biotec IPO is 22-Nov-2024.
What is the purpose for the Onyx Biotec IPO?
The purpose of this IPO is to raise fresh capital.
How much times Onyx Biotec IPO subscribed?
Onyx Biotec total subscription ratio is 183.9X.
What are the key financials for the Onyx Biotec IPO?
Key financial of the Onyx Biotec are:
| Onyx Biotec | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 53.75 | 39.48 | 44.86 |
| EBIT (₹ Cr) | 6.52 | 3 | 4.32 |
| Proft after Tax (₹ Cr) | 3.63 | 1.84 | 3.35 |
| Debt (₹ Cr) | 30.78 | 29.23 | 12.24 |
| Net Worth (₹ Cr) | 25.29 | 18.2 | 16.38 |
| RoE (%) | 14.37 | 10.13 | 20.47 |